| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |